N+1 Singer reissued their corporate rating on shares of CVS Group Plc (LON:CVSG) in a research report report published on Thursday.
Several other research analysts have also recently commented on the company. Berenberg Bank raised their target price on CVS Group Plc from GBX 880 ($10.92) to GBX 910 ($11.29) and gave the stock a buy rating in a research report on Friday, July 29th. Investec reaffirmed a buy rating and issued a GBX 880 ($10.92) target price on shares of CVS Group Plc in a research report on Tuesday, August 2nd. Finally, Peel Hunt cut CVS Group Plc to an add rating and raised their target price for the stock from GBX 950 ($11.79) to GBX 1,000 ($12.41) in a research report on Friday, September 23rd.
CVS Group Plc (LON:CVSG) opened at 1058.5645 on Thursday. The company has a 50-day moving average of GBX 883.89 and a 200-day moving average of GBX 842.11. CVS Group Plc has a 12 month low of GBX 645.00 and a 12 month high of GBX 1,075.00. The company’s market cap is GBX 635.12 million.
The business also recently disclosed a dividend, which will be paid on Friday, December 9th. Shareholders of record on Thursday, November 24th will be issued a dividend of GBX 3.50 ($0.04) per share. The ex-dividend date is Thursday, November 24th. This is a boost from CVS Group Plc’s previous dividend of $3.00. This represents a dividend yield of 0.37%.
In related news, insider Mike McCollum acquired 3,049 shares of the business’s stock in a transaction on Friday, October 21st. The stock was bought at an average cost of GBX 862 ($10.69) per share, with a total value of £26,282.38 ($32,604.37). Also, insider Simon Innes acquired 5,750 shares of the business’s stock in a transaction on Tuesday, November 15th. The shares were bought at an average cost of GBX 867 ($10.76) per share, with a total value of £49,852.50 ($61,844.06).